Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone and PD-1 Inhibitor +/- Radiotherapy in Advanced pMMR/MSS Colorectal Cancer
NCT07644286Phase 2Recruiting
- Start
- Dec 2025
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in colorectal cancer (CRC). Started Dec 2025; status: recruiting.
02
Drugs
pirfenidone
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07644286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07644286.